Phosphatidylserine: Benefits, Forms, Dosing, and Side Effects

Phosphatidylserine (PS) is a phospholipid that forms a critical structural component of cell membranes throughout the body, with particularly high concentrations in the brain. Research interest began in the 1980s when bovine brain-derived PS showed promising results for Alzheimer's disease and cognitive decline — but that form is no longer available due to BSE (mad cow disease) safety concerns. Modern supplements derived from soy or sunflower lecithin have a different fatty acid composition and have shown considerably weaker cognitive benefits. This article examines the full evidence base for phosphatidylserine, including cognitive function, cortisol modulation, exercise recovery, recommended dosing, safety, and drug interactions.

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Phosphatidylserine (PS) is a phospholipid — a fatty substance that forms a critical structural component of cell membranes in all living organisms [1][2]. It belongs to the glycerophospholipid class, characterized by a glycerol backbone linked to two fatty acid chains, a phosphate group, and a serine amino acid head group [2][3]. This structure distinguishes it from other major phospholipids such as phosphatidylcholine (which has a choline head group) and phosphatidylethanolamine (which has an ethanolamine head group) [2].

In cell membranes, phosphatidylserine is predominantly located in the inner leaflet of the plasma membrane, where it contributes to membrane fluidity, curvature, and asymmetry [2][3]. This asymmetric distribution is biologically important: when phosphatidylserine is exposed on the outer leaflet of the cell membrane, it serves as an "eat me" signal for macrophages to clear apoptotic (dying) cells, and it plays a role in blood coagulation by providing a surface for clotting factor assembly [2][4][5].

The brain contains a particularly high concentration of phosphatidylserine, accounting for approximately 13% of the total phospholipids in neural tissue, with higher levels in gray matter and synaptic membranes compared to other tissues [2][3]. In neuronal membranes, PS plays an essential role in facilitating nerve cell signaling by modulating the activity of membrane-bound proteins, including ion channels, receptors, and enzymes involved in neurotransmitter release and synaptic transmission [1][2][3]. It is involved in cell-to-cell communication in the brain, supporting the release and activity of acetylcholine, dopamine, and serotonin — neurotransmitters critical for memory, mood, and cognitive function [2][3].

Endogenous synthesis of phosphatidylserine in mammalian cells occurs primarily through a base-exchange reaction in the endoplasmic reticulum, where phosphatidylserine synthases (PSS1 and PSS2) catalyze the replacement of the choline or ethanolamine head group of phosphatidylcholine or phosphatidylethanolamine with serine [2][3]. While the body can synthesize PS, endogenous production may decline with age, and dietary intake from foods such as organ meats, fish, and soy lecithin provides additional supply [1][6]. Typical dietary intake of phosphatidylserine from food is estimated at 130-180 mg per day in Western diets, with higher intakes in populations that consume more organ meats and fish [6].

Research interest in phosphatidylserine supplementation began in the late 1980s and early 1990s, when studies using bovine (cow) brain-derived PS showed promising results for Alzheimer's disease and age-related cognitive decline [1][7][8]. However, concerns about bovine spongiform encephalopathy (BSE, or "mad cow disease") led the FDA to conclude in 2003 that phosphatidylserine supplements should not be derived from bovine brain tissue from countries where BSE exists [1][9]. As a result, nearly all phosphatidylserine supplements on the market today are derived from plant sources — primarily soy lecithin or sunflower lecithin — which have a different fatty acid composition than the original bovine-derived form [1][10].

In 2003, the FDA permitted two qualified health claims for phosphatidylserine supplements derived from soy or bovine sources: (1) "Consumption of phosphatidylserine may reduce the risk of dementia in the elderly," and (2) "Consumption of phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly" [9][11]. However, both claims must carry the disclaimer: "Very limited and preliminary scientific research suggests that phosphatidylserine may reduce the risk of dementia [or cognitive dysfunction] in the elderly. FDA concludes that there is little scientific evidence supporting this claim" [9][11]. This unusual pairing of a permitted claim with a contradictory disclaimer reflects the state of the evidence: promising but far from definitive.

Forms and Bioavailability

Bovine-Derived vs. Plant-Derived Phosphatidylserine

The critical distinction in phosphatidylserine supplementation is between the original bovine brain-derived form and the modern plant-derived forms. This distinction has significant implications for efficacy because the two sources have fundamentally different fatty acid compositions.

Bovine cortex-derived PS contains predominantly long-chain polyunsaturated fatty acids — particularly docosahexaenoic acid (DHA) and stearic acid — attached to the glycerol backbone [1][10]. The early clinical trials that demonstrated benefit in Alzheimer's disease and cognitive decline all used this bovine-derived form [7][8]. However, bovine brain-derived PS is no longer commercially available due to BSE safety concerns [1][9].

Soy lecithin-derived PS is the most commonly used plant source. It contains predominantly shorter-chain, saturated and monounsaturated fatty acids (primarily palmitic and oleic acid) rather than the DHA and stearic acid found in bovine PS [1][10]. This difference in fatty acid profile may explain why plant-derived PS has shown less robust cognitive benefits in clinical trials compared to the bovine form [1][10][12]. Soy-derived PS is the form with the most clinical research among plant-based options.

Sunflower lecithin-derived PS is a newer alternative that avoids both BSE concerns and soy allergens. It is manufactured from sunflower seed oil and provides phosphatidylserine with a fatty acid composition similar to soy-derived PS [2]. While more clinical research has been conducted with soy-derived products, it is not clear if there is a meaningful difference in biological activity between soy-derived and sunflower-derived PS [1]. The sunflower-derived option is particularly relevant for individuals with soy allergies or those seeking non-GMO alternatives.

DHA-Conjugated Phosphatidylserine (PS-DHA)

To address the efficacy gap between bovine and plant-derived PS, modified forms have been developed in which omega-3 fatty acids — particularly DHA — are chemically attached to the soy-derived phosphatidylserine backbone [1][13][14][15]. These products aim to more closely mimic the fatty acid profile of the original bovine brain-derived PS.

The most studied DHA-conjugated PS product was Sharp-PS Gold (also previously marketed as Vayacog, manufactured by Enzymotec Ltd.) [1][13][14][15]. This form has shown some cognitive benefits in clinical trials, particularly for sustained attention and memory recall in non-demented elderly people with memory complaints [13][14][15]. However, production of Vayacog has ceased. The same formula sold as Sharp-PS Gold can be found in limited commercial products [1].

Absorption and Bioavailability

Supplemental phosphatidylserine is absorbed in the gastrointestinal tract and incorporated into cell membranes, particularly in the brain [2][3]. Taking phosphatidylserine with a meal is generally recommended, possibly to enhance absorption through co-ingestion with dietary fats, which may facilitate micellar solubilization and intestinal uptake of this lipophilic compound [1]. The phospholipid structure of PS allows it to be incorporated into chylomicrons and other lipoprotein particles for transport, and it crosses the blood-brain barrier, where it can be incorporated into neuronal membranes [2][3].

Once absorbed, supplemental PS is thought to exert its effects by being incorporated into cell membranes, where it may enhance membrane fluidity [2][3]. Increased membrane fluidity can facilitate the optimal functioning of membrane-bound proteins, including receptors, ion channels, and enzymes, thereby supporting efficient signal transduction and cellular communication [2]. Supplemental PS provides an exogenous supply that may help replenish membrane PS content when endogenous levels are insufficient due to aging, stress, or other factors [2][3].

Form Comparison Table

Form	Source	Fatty Acid Profile	Clinical Evidence	Availability
Bovine brain-derived PS	Cow brain tissue	DHA, stearic acid (long-chain PUFA)	Strong: multiple RCTs for Alzheimer's and cognitive decline [7][8][16]	No longer available (BSE concerns) [1][9]
Soy lecithin-derived PS	Soybean oil	Palmitic, oleic acid (shorter-chain)	Modest or no benefit for cognition [1][10][12]; moderate for cortisol [18][20][21]	Widely available
Sunflower lecithin-derived PS	Sunflower seed oil	Similar to soy-derived	Limited clinical data	Increasingly available
PS-DHA conjugate (Sharp-PS Gold)	Modified soy + DHA	DHA attached to PS backbone	Some benefit for attention and memory in elderly [13][14][15]	Limited availability

Evidence for Benefits

Memory and Cognitive Function

Early Bovine-Derived PS Studies (1980s-1990s)

The earliest and most compelling evidence for phosphatidylserine and cognition came from studies using bovine brain-derived PS, conducted primarily in the late 1980s through the mid-1990s.

Amaducci et al. (1988) conducted one of the earliest multicenter studies of bovine-derived PS in patients with early Alzheimer's disease. Participants received 300 mg/day of bovine cortex-derived PS for 3 months and showed significant improvements in several cognitive measures compared to baseline [16].

Crook et al. (1991) conducted a landmark double-blind, placebo-controlled trial in 149 patients aged 50-75 meeting criteria for age-associated memory impairment. Participants received 100 mg of bovine cortex-derived PS three times daily (300 mg/day) or placebo for 12 weeks. The PS group showed significant improvements in learning and recall of names, faces, and paragraphs compared to placebo. The greatest benefits were observed in participants who performed in the lower third at baseline. Improvements regressed toward pretreatment levels during a subsequent 4-week washout period, suggesting benefits required ongoing supplementation [7].

Cenacchi et al. (1993) conducted the largest early trial — a multicenter, double-blind, placebo-controlled study in 425 elderly patients aged 65-93 with moderate to severe cognitive decline. Participants received 300 mg/day of bovine cortex-derived PS or placebo for 6 months. The PS group showed statistically significant improvements in behavioral and cognitive parameters compared to placebo, including improvements in daily activities and social behavior [8].

These early trials were the basis for the FDA's 2003 qualified health claim. However, because bovine brain-derived PS is no longer available due to BSE concerns, these results cannot be directly applied to modern plant-derived supplements [1][9].

Plant-Derived PS Studies

Studies using soy-derived or sunflower-derived phosphatidylserine at doses of 100-600 mg daily have shown very modest or no benefit for cognitive function or age-related memory impairment [1][10][12].

Jorissen et al. (2001) conducted a randomized, double-blind, placebo-controlled trial investigating soy-derived PS in elderly subjects with age-associated memory impairment. The study tested two doses — 300 mg/day and 600 mg/day — for 12 weeks. Neither dose produced significant improvements in cognitive function compared to placebo [12].

Kato-Kataoka et al. (2010) conducted a randomized, double-blind, placebo-controlled trial examining soy-derived PS (100 mg/day) in elderly Japanese subjects with memory complaints. The study reported modest improvements in delayed verbal recall in a subset of participants with low baseline cognitive scores, but overall results were not robustly positive [10].

Richter et al. (2013) conducted a systematic review of human PS supplementation studies and concluded that while bovine-derived PS showed clear cognitive benefits, the evidence for plant-derived PS was considerably weaker, likely due to the different fatty acid compositions [17].

DHA-Conjugated PS Studies

To bridge the efficacy gap, researchers developed PS-DHA conjugates — soy-derived PS with omega-3 fatty acids (particularly DHA) chemically attached.

Richter et al. (2010) conducted a pilot study of PS-DHA (Sharp-PS Gold) in elderly subjects with memory complaints. Participants showed improvements in sustained attention and memory recall, providing initial signals that the DHA-conjugated form might offer cognitive benefits superior to standard plant-derived PS [13].

Vakhapova et al. (2010) conducted the pivotal double-blind, placebo-controlled trial of PS-DHA. A total of 157 non-demented elderly participants with memory complaints received either PS-DHA (Vayacog, 300 mg/day) or placebo for 15 weeks. The PS-DHA group showed significant improvements in sustained attention and total learning compared to placebo. A subgroup analysis revealed that the greatest benefits were in participants who already performed relatively well on cognitive tests before treatment [14].

Vakhapova et al. (2014) published a follow-up extension study. Participants who had received PS-DHA for 15 weeks showed sustained improvements in verbal immediate recall. Benefits were most pronounced in those with higher baseline cognitive functioning [15].

Summary of Cognitive Evidence

PS Form	Evidence Level	Key Findings
Bovine-derived (300 mg/day)	Strong (multiple RCTs)	Significant benefit for cognitive decline and Alzheimer's; greatest benefit in most impaired; effects reverse on cessation [7][8][16]
Plant-derived soy/sunflower (100-600 mg/day)	Weak	Very modest or no benefit for cognition [1][10][12]
PS-DHA conjugate (100-300 mg/day)	Moderate (limited trials)	Some benefit for attention and memory in non-demented elderly [13][14][15]
FDA position	Qualified claim with disclaimer	"Very limited and preliminary scientific research" — "little scientific evidence" [9][11]

Cortisol and Stress Response

Phosphatidylserine has been studied for its effects on the hypothalamic-pituitary-adrenal (HPA) axis — the body's central stress response system. The proposed mechanism involves PS modulating the sensitivity of the HPA axis, potentially attenuating the release of adrenocorticotropic hormone (ACTH) and cortisol during stress [2][3][18][19].

Monteleone et al. (1990, 1992) conducted foundational studies on PS and the cortisol response. Bovine cortex-derived PS (800 mg/day for 10 days) significantly blunted the rise in ACTH and cortisol following standardized physical stress in healthy men compared to placebo. In a subsequent study, chronic PS administration again demonstrated significant attenuation of the stress-induced activation of the HPA axis [18].

Benton et al. (2001) studied soy-derived PS at 300 mg/day for 30 days in young healthy adults. Participants who received PS reported feeling calmer and less stressed during cognitive testing. Heart rate responses to the stressor were also reduced. However, the cortisol-lowering effect was not consistently significant across all measures [22].

Hellhammer et al. (2004) investigated soy lecithin-derived phosphatidic acid and phosphatidylserine complex (PAS, 400 mg/day containing approximately 100 mg PS) in 80 healthy young adults. The PAS complex significantly attenuated the serum ACTH and cortisol response to the Trier Social Stress Test. The cortisol-blunting effect was most pronounced in subjects classified as chronically stressed [20].

Baumeister et al. (2008) examined soy-derived PS at 300 mg/day for 42 days in young healthy men. PS reduced cortisol and heart rate responses to a mental arithmetic stress test. Participants also showed improved cognitive performance under stress. EEG measurements confirmed PS-related changes in cortical activity during stress [21].

The cortisol-modulating evidence for PS is more consistent than the cognitive evidence for plant-derived forms. Multiple studies using both bovine and plant-derived PS at doses of 300-800 mg/day over periods as short as 10 days have demonstrated meaningful cortisol blunting [18][19][20][21][22]. However, reducing cortisol is not inherently beneficial in all contexts — cortisol is essential for normal immune function, glucose regulation, and the fight-or-flight response.

Athletic Performance and Exercise Recovery

Phosphatidylserine has been investigated for effects on exercise performance and recovery, primarily through its cortisol-modulating properties.

Monteleone et al. (1992) demonstrated that 800 mg/day of bovine-derived PS for 10 days significantly blunted the cortisol response to physical exercise stress, providing the initial rationale for PS use in athletic contexts [18].

Fahey et al. (1998) studied 800 mg/day of soybean-derived PS for two weeks in 11 trained men. The study found less of an increase in muscle soreness in the PS group compared to placebo, but it is not clear if this finding was statistically significant. This study was published only as an abstract [1][23].

Kingsley et al. (2006) conducted two studies examining 750 mg/day of soy-derived PS for 10 days. In cyclists, PS resulted in a trend toward improved exercise time to exhaustion, but the effect did not reach statistical significance. In a separate intermittent running study, PS tended to reduce markers of oxidative stress but exercise capacity improvements were not significant [24][25].

Jager et al. (2007) reported that soy-derived PS could modestly reduce the cortisol response to intense exercise but did not demonstrate clear improvements in athletic performance measures [19].

Starks et al. (2008) investigated 600 mg/day of soy-derived PS for 10 days in resistance-trained men. PS reduced cortisol levels by approximately 20% following exercise. However, no significant differences in testosterone, testosterone-to-cortisol ratio, growth hormone, or muscle soreness were observed [26].

Overall, studies show PS at 600-800 mg/day can modestly reduce exercise-induced cortisol elevation, but there is no strong evidence this translates into improvements in athletic performance, strength, power, or body composition [1][19].

ADHD and Attention in Children

Hirayama et al. (2014) conducted a randomized, double-blind, placebo-controlled trial of soy-derived PS (200 mg/day for 2 months) in 36 children aged 4-14 with ADHD. The PS group showed significant improvements in short-term auditory memory and inattention scores compared to placebo. However, the study was small and requires replication [27].

Manor et al. (2012) studied PS-omega-3 at 300 mg/day for 30 weeks in 200 children with ADHD. The PS-omega-3 group did not show significant improvements over placebo in the overall population, but a subgroup of children with more pronounced hyperactive-impulsive behavior and mood dysregulation showed improvement [28].

The evidence for PS in ADHD is preliminary. PS cannot be recommended as a treatment for ADHD based on current evidence, and it should not replace established therapies.

Depression and Mood

Benton et al. (2001) found that soy-derived PS at 300 mg/day for 30 days improved mood and reduced perceived stress in young healthy adults during cognitive testing [22]. Baumeister et al. (2008) reported improved mood state alongside reduced cortisol responses in young men taking 300 mg/day for 42 days [21]. Hellhammer et al. (2004) showed improved well-being in chronically stressed individuals taking a PS-phosphatidic acid complex [20].

No large-scale RCT has specifically evaluated PS as a treatment for clinical depression. The mood-related effects appear secondary to cortisol modulation rather than a direct antidepressant mechanism.

Mechanism of Action: HPA Axis Modulation

The most consistently demonstrated mechanism of supplemental PS is its modulation of the hypothalamic-pituitary-adrenal (HPA) axis [2][3][18][20]:

• Membrane integration: Supplemental PS is absorbed and incorporated into cell membranes in the brain and adrenal glands, potentially increasing membrane fluidity
• CRH receptor modulation: PS may reduce the sensitivity of corticotropin-releasing hormone receptors in the hypothalamus, leading to reduced ACTH secretion
• Cortisol attenuation: Reduced ACTH stimulation results in lower cortisol output from the adrenal glands during stress
• Neurotransmitter effects: PS may support acetylcholine release and modulate dopaminergic and serotonergic systems [2][3]

Phosphatidylcholine and Choline Connection

The source material for phosphatidylserine — lecithin — is also the primary source of phosphatidylcholine, which provides choline, a precursor to the neurotransmitter acetylcholine [1]. There is limited evidence that phosphatidylcholine itself improves memory or cognition. Other forms of choline — particularly citicoline (CDP-choline) and alpha-GPC — have shown more promise for cognitive support [1].

Recommended Dosing

General Guidelines

Studies using phosphatidylserine for cognitive improvement have typically used 200-800 mg daily [1][2]. Daily doses of 300 mg or more are often divided into three doses (100 mg three times daily with meals) [1][7][8]. Taking PS with a meal is generally recommended to enhance absorption [1].

Dosing by Indication

Indication	Dose	Duration	Evidence Level
Age-related cognitive decline	100-300 mg/day, divided into 2-3 doses	12+ weeks	Modest (plant-derived); Strong (bovine, no longer available) [1][7][8][10][12]
Cortisol reduction / stress	400-800 mg/day	10-42 days	Moderate [18][19][20][21]
Exercise cortisol blunting	600-800 mg/day	10-14 days	Moderate (cortisol); Weak (performance) [18][19][26]
Memory support (PS-DHA form)	100-300 mg/day PS-DHA	15+ weeks	Moderate in non-demented elderly [13][14][15]
ADHD (children)	200-300 mg/day	2-7 months	Preliminary [27][28]

Practical Considerations

• Divide doses above 300 mg/day. Most cognitive studies used 100 mg three times daily rather than a single large dose [7][8].
• Take with food. Fat-containing meals may improve absorption of this lipophilic phospholipid [1].
• Soy vs. sunflower source. More clinical research has been conducted with soy-derived PS, but no meaningful difference in activity between sources has been established [1].
• PS-DHA forms. If available, DHA-conjugated PS may offer more cognitive benefit than standard plant-derived PS [14][15]. However, availability is limited.
• Duration of use. Cognitive benefits in the Crook et al. (1991) trial regressed during washout, suggesting ongoing supplementation may be necessary [7].
• Combining with omega-3s. Taking plant-derived PS alongside fish oil could theoretically mimic the fatty acid profile of bovine PS, but this specific combination has not been tested in clinical trials.

Important Context

The most impressive cognitive results came from bovine-derived PS, which is no longer available [7][8][16]. Modern plant-derived PS has shown very modest or no cognitive benefit [1][10][12]. The cortisol-reduction evidence is stronger and more consistent than the cognitive evidence for plant-derived PS [18][19][20][21]. The FDA's own disclaimers state there is "little scientific evidence" supporting cognitive claims [9][11].

Safety and Side Effects

General Safety Profile

Phosphatidylserine appears to be safe based on short-term studies (6 to 12 weeks) using soy lecithin-derived products at doses of up to 600 mg/day with meals [1][12]. Clinical trials using doses up to 800 mg daily have reported low incidence of adverse events comparable to placebo, with no serious adverse effects [2][3][18][19].

Common Side Effects

• Gastrointestinal discomfort: Nausea, bloating, gas, and stomach upset, particularly at higher doses or without food
• Insomnia or sleep disturbances: Occasionally reported, especially when taken close to bedtime or above 300 mg/day
• Headache: Rarely reported in clinical trials

These effects are typically transient and resolve with dose adjustment or discontinuation [2].

Long-Term Safety

Long-term safety data beyond several months is limited. The longest trials lasted approximately 6-7 months [8][28]. Available evidence suggests no major concerns for healthy adults, but comprehensive data spanning years of use is lacking.

Special Populations

• Pregnancy and breastfeeding: Insufficient safety data. Use not recommended without medical supervision [2].
• Children: Limited data. Two trials used PS in children with ADHD without significant adverse effects [27][28], but the evidence base is too small for firm conclusions.
• Soy allergy: Use sunflower-derived PS products to avoid soy allergens [1][2].

Blood Clotting Considerations

Phosphatidylserine plays a physiological role in blood clotting. When externalized on cell surfaces, it provides a catalytic surface for coagulation factor assembly [4][5]. This procoagulant role means supplemental PS could theoretically affect hemostasis, although clinical trials have not reported increased clotting events. Individuals taking anticoagulant or antiplatelet medications should exercise caution [1][4][5].

Drug Interactions

Anticoagulants and Antiplatelet Agents

Due to phosphatidylserine's role in blood clotting, there is a theoretical interaction with blood thinners [1][4][5]. While no clinical cases have been formally reported, medications of concern include:

• Warfarin (Coumadin)
• Heparin and low-molecular-weight heparins
• Direct oral anticoagulants: apixaban, rivaroxaban, dabigatran, edoxaban
• Antiplatelet drugs: aspirin, clopidogrel, ticagrelor, prasugrel
• Blood-thinning supplements: fish oil/omega-3, vitamin E, ginkgo biloba

Anticholinergic Medications

Phosphatidylserine may support acetylcholine activity in the brain, potentially counteracting anticholinergic medications [2]. This interaction is theoretical. Relevant drugs include diphenhydramine, hydroxyzine, amitriptyline, oxybutynin, and cyclobenzaprine.

Cholinesterase Inhibitors

PS's cholinergic effects could theoretically potentiate cholinesterase inhibitors used in Alzheimer's treatment (donepezil, rivastigmine, galantamine), potentially increasing both benefits and cholinergic side effects.

Cortisol-Modulating Substances

PS's cortisol-lowering effects could compound with other HPA axis modulators, including ashwagandha, rhodiola rosea, and high-dose fish oil. No specific adverse interactions have been documented, but combining multiple cortisol-modulating supplements could theoretically produce excessive cortisol suppression.

Dietary Sources

Phosphatidylserine can be obtained from the diet — primarily from animal sources, with some plant-based foods providing small amounts [1][6]. The average Western diet provides an estimated 130-180 mg of PS per day [6].

Animal Sources (High PS Content)

Food	PS Content (mg per 100g)
Cow brain	713
Atlantic mackerel	480
Chicken heart	414
Atlantic herring	360
Eel	335
Tuna	194
Chicken leg	134
Chicken liver	123
Soft-shell clam	87
Chicken breast	85
Veal	72
Beef	69
Pork	57
Atlantic cod	28
Anchovy	25

Plant Sources and Dairy (Lower PS Content)

Food	PS Content (mg per 100g)
White beans (navy, cannellini, great northern)	107
Whole grain barley	20
Soy lecithin	10-20
Rice (unpolished)	3
Carrot	2
Potato	1
Cow's milk (3.5% fat)	1

Source: Souci, Food Composition and Nutrition Tables, 2008 [6].

Practical Notes on Dietary PS

• Animal sources dominate. Organ meats and fatty fish provide the highest concentrations. Modern Western diets have moved away from organ meat consumption, reducing dietary PS intake [6].
• Fish is the most practical rich source. A 200g serving of mackerel provides approximately 960 mg of PS — well above clinical trial doses [6].
• White beans are the best plant source at 107 mg per 100g. Other plant sources provide only trace amounts [6].
• Diet vs. supplementation. Typical dietary intake of 130-180 mg/day falls below the 300-800 mg/day doses used in clinical trials. Achieving therapeutic doses through food alone would require large quantities of fatty fish or organ meats [6].
• Fatty acid context. Fish-sourced dietary PS naturally contains DHA — the fatty acid profile that characterized the original effective bovine supplements but that plant-derived supplements lack [1][6][10].

References

1. ConsumerLab. "Phosphatidylserine Supplements Review." Accessed 2026. https://www.consumerlab.com/reviews/phosphatidylserine-supplements/phosphatidylserine/

Choline is a key building block for brain phospholipids including phosphatidylserine. MicroVitamin includes CDP-Choline (citicoline) at 500 mg — a highly bioavailable choline source that crosses the blood-brain barrier and supports phospholipid synthesis in neural tissue.

2. Grokipedia. "Phosphatidylserine." https://grokipedia.com/page/Doctors_Best_Phosphatidylserine

3. Kim HY, Huang BX, Spector AA. "Phosphatidylserine in the brain: metabolism and function." Prog Lipid Res. 2014;56:1-18. https://doi.org/10.1016/j.plipres.2014.06.002

4. Wang J, et al. "Phosphatidylserine externalization as a biomarker." Biomark Res. 2022. https://doi.org/10.1186/s40364-022-00428-x

5. Tersenov OA. "Phosphatidylserine and blood clotting." Vopr Med Khim. 1981;27(3):289-294.

6. Souci SW, Fachmann W, Kraut H. Food Composition and Nutrition Tables. 7th ed. MedPharm Scientific Publishers; 2008.

7. Crook TH, Tinklenberg J, Yesavage J, et al. "Effects of phosphatidylserine in age-associated memory impairment." Neurology. 1991;41(5):644-649. https://doi.org/10.1212/WNL.41.5.644

8. Cenacchi T, Bertoldin T, Farina C, et al. "Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration." Aging (Milano). 1993;5(2):123-133. https://pubmed.ncbi.nlm.nih.gov/8323999/

9. U.S. Food and Drug Administration. "Phosphatidylserine and Cognitive Dysfunction and Dementia (Qualified Health Claim: Final Decision Letter)." May 2003. https://www.fda.gov/food/cfsan-constituent-updates/phosphatidylserine-and-cognitive-dysfunction-and-dementia

10. Kato-Kataoka A, Sakai M, Ebina R, et al. "Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints." J Clin Biochem Nutr. 2010;47(3):246-255. https://doi.org/10.3164/jcbn.10-62

11. U.S. Food and Drug Administration. "Qualified Health Claims: Letter of Enforcement Discretion — Phosphatidylserine and Cognitive Dysfunction and Dementia." November 2004.

12. Jorissen BL, Brouns F, Van Boxtel MP, et al. "The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment." Nutr Neurosci. 2001;4(2):121-134. https://doi.org/10.1080/1028415X.2001.11747356

13. Richter Y, Herzog Y, Cohen T, et al. "The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study." Clin Interv Aging. 2010;5:313-316. https://doi.org/10.2147/CIA.S13432

14. Vakhapova V, Cohen T, Richter Y, et al. "Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial." Dement Geriatr Cogn Disord. 2010;29(5):467-474. https://doi.org/10.1159/000310330

15. Vakhapova V, Cohen T, Richter Y, et al. "Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study." Dement Geriatr Cogn Disord. 2014;38(1-2):39-45. https://doi.org/10.1159/000357793

16. Amaducci L, SMID Group. "Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study." Psychopharmacol Bull. 1988;24(1):130-134. https://pubmed.ncbi.nlm.nih.gov/3290935/

17. Richter Y, Herzog Y, Lifshitz Y, et al. "The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a systematic review." Clin Nutr ESPEN. 2013.

18. Monteleone P, Beinat L, Tanzillo C, et al. "Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans." Neuroendocrinology. 1990;52(6):609-613. https://doi.org/10.1159/000125650. Also: Monteleone P, et al. "Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men." Eur J Clin Pharmacol. 1992;42(4):385-388. https://doi.org/10.1007/BF00280123

19. Jager R, Purpura M, Geiss KR, et al. "The effect of phosphatidylserine on golf performance." J Int Soc Sports Nutr. 2007;4:23. https://doi.org/10.1186/1550-2783-4-23

20. Hellhammer J, Fries E, Buss C, et al. "Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress." Stress. 2004;7(2):119-126. https://doi.org/10.1080/10253890410001728379

21. Baumeister J, Barthel T, Geiss KR, et al. "Influence of phosphatidylserine on cognitive performance and cortical activity after induced stress." Nutr Neurosci. 2008;11(1):11-18. https://doi.org/10.1179/147683008X301478

22. Benton D, Donohoe RT, Sillance B, et al. "The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor." Nutr Neurosci. 2001;4(3):169-178. https://doi.org/10.1080/1028415X.2001.11747360

23. Fahey TD, Pearl M. "The hormonal and perceptive effects of phosphatidylserine administration during two weeks of resistive exercise-induced overtraining." Biol Sport. 1998;15:135-144.

24. Kingsley MI, Wadsworth D, Kilduff LP, et al. "Effects of phosphatidylserine on exercise capacity during cycling in active males." Med Sci Sports Exerc. 2006;38(1):64-71. https://doi.org/10.1249/01.mss.0000183195.10867.d0

25. Kingsley MI, Miller M, Kilduff LP, et al. "Effects of phosphatidylserine on oxidative stress following intermittent running." Med Sci Sports Exerc. 2006;38(7):1341-1349. https://doi.org/10.1249/01.mss.0000227320.53056.c4

26. Starks MA, Starks SL, Kingsley M, et al. "The effects of phosphatidylserine on endocrine response to moderate intensity exercise." J Int Soc Sports Nutr. 2008;5:11. https://doi.org/10.1186/1550-2783-5-11

27. Hirayama S, Masuda Y, Rabeler R. "Effect of phosphatidylserine administration on symptoms of attention-deficit/hyperactivity disorder in children." Agro Food Ind Hi-Tech. 2014;25:56-59.

28. Manor I, Magen A, Keidar D, et al. "The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension." Eur Psychiatry. 2012;27(5):335-342. https://doi.org/10.1016/j.eurpsy.2011.05.004